Which medications in the drug class Dopamine/Norepinephrine Reuptake Inhibitors are used in the treatment of Narcolepsy?

Updated: Sep 04, 2019
  • Author: Sagarika Nallu, MD; Chief Editor: Selim R Benbadis, MD  more...
  • Print

Dopamine/Norepinephrine Reuptake Inhibitors

The mechanism of action by which solriamfetol improves wakefulness in patients with excessive daytime sleepiness associated with narcolepsy is unclear, but is thought to be mediated through its inhibition of dopamine/norepinephrine reuptake. 

Solriamfetol (Sunosi)

Dopamine/norepinephrine reuptake inhibitor (DNRI). It is indicated to improve wakefulness in adults with excessive daytime sleepiness associated with narcolepsy.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!